News

Cook Medical endovascular grafts recalled due to risk of coating breaking off, entering patient’s bloodstream.

Customers are urged to examine their inventory, quarantine any unused products and return them to the manufacturer. 

Congress Money washington DC legislation coverage payment

Healthcare policies have rapidly evolved in recent years, and 2025 was no exception. From payment policies to physician shortages, ASE and other medical societies had plenty to fight for throughout the year.

heart surgery cardiac surgeons

There is a risk that these catheters will fail to retain their shape during use, causing procedure delays and creating the risk of an adverse outcome. The FDA first warned users about the issue back in August.

FDA recall medical device recall product recall

Three patient deaths have been linked to connectivity issues with these devices. The FDA has classified this as a Class I recall.

Prenuvo MRI

Sean Clifford filed the lawsuit Sept. 24, 2024, in the New York State Supreme Court, contending a radiologist failed to spot signs of a forthcoming stroke.   

insurance insurer payment claim denial reimbursement prior authorization

This utilization management tactic disproportionately affects specialties such as diagnostic radiology, radiation oncology and cardiology. 

IV hospital room intravenous drip solution

As IR procedure volumes continue to climb, coupled with anesthesiology provider shortages, there is growing interest in achieving “deeper, more reliable sedation.” 

healthcare surprise billing statement payment

A new analysis claims the “benchmark” qualifying payment amount insurers calculate often “dramatically” understates the actual median in-network rates they are paying for in-network care.  

Thumbnail

TPG will not own a majority of the e-prescriber, with CVS Health and Express Scripts maintaining a minority stake.

The Texas State Capital building in Austin where 140 scope creep bills were defeated in 2024 by the Texas medical Association.

Two weeks ago, the FTC launched a similar antitrust suit. The pharmacy benefit managers and pharmaceutical companies are accused of artificially raising drug costs through rebates and kickbacks.

Medtronic's MiniMed 780 (left) and 670 (right) insulin pumps in FDA recall

Some of Medtronic's 600 and 700 series MiniMed insulin pumps are experiencing significant battery issues when dropped, bumped or impacted in any way. This has been linked to reports of health issues in more than 180 patients.

Several such IR procedures require US guidance, but a new study is questioning the modality’s effectiveness in reducing complication rates. 

Around the web

Customers are urged to examine their inventory, quarantine any unused products and return them to the manufacturer.